Pharma Focus America

Thermo Fisher Scientific Launches New GMP-Certified Ultra-Cold Facility in EU to Boost Advanced Therapies Development

Monday, June 03, 2024

Thermo Fisher Scientific Inc., known for its dedication to scientific advancement, has recently opened a cutting-edge clinical and commercial ultra-cold facility in the EU. This facility, situated in Bleiswijk, Netherlands, represents a significant expansion of the company's clinical trial network in Europe, aimed at accelerating the development of advanced therapies.

Tailoring its services to pharmaceutical and biopharmaceutical clients, Thermo Fisher's new facility offers comprehensive support throughout the clinical supply chain for high-value therapies such as cell and gene therapies, biologics, antibodies, and vaccines. The company aims to meet the increasing demand for cell and gene therapy clinical trials in Europe by leveraging its expertise in bioservices and specialty logistics, including biorepository solutions and critical material storage.

Thermo Fisher Scientific, expressed excitement about the facility's opening, highlighting its role in supporting the development of innovative therapies. Located just 30 minutes outside Amsterdam, the site offers a range of services, including clinical and commercial packaging, biorepository storage, and supply chain management for cell and gene therapy products.

In line with Thermo Fisher's commitment to sustainability, the Bleiswijk site incorporates eco-friendly practices, utilizing solar power, electric heat pumps for heating and cooling, and advanced heat recovery technology. The company aims to achieve net-zero emissions by 2050 as part of its global sustainability goals.

This expansion in Europe complements Thermo Fisher's recent developments worldwide, including the expansion of biologics manufacturing capacity in St. Louis, the establishment of a cell therapy manufacturing facility in San Francisco, and the launch of an Innovation Lab in Pennsylvania. 



Thermo Fisher Scientific - mRNA ServicesFuture Labs Live USA 2024World Vaccine Congress Europe 2024World Orphan Drug Congress 2024Advanced Therapies USA 2024World Orphan Drug Congress Europe 2024